| Literature DB >> 28947672 |
Xiaofei Wang1, Haiyan Han1,2, Zhihui Lv1, Zhiwei Lin1, Yongpeng Shang1, Tao Xu3, Yang Wu1, Ying Zhang4,5, Di Qu6.
Abstract
PhoU, a conserved protein that has been proposed to coordinate phosphate import, is a negative regulator of drug tolerance in most bacteria. In Staphylococcus epidermidis, the role of PhoU in biofilm formation and drug tolerance has not yet been investigated. Two PhoU homologs in the genome of S. epidermidis have been identified by the presence of the conserved motif E(D)XXXD of PhoU. We separately constructed ΔphoU1 and ΔphoU2 mutants of S. epidermidis strain 1457. The ΔphoU2 mutant displayed growth retardation, a weakened biofilm formation capacity, a higher sensitivity to H2O2, and reduced tolerance to multiple antibiotics. However, deletion of phoU1 had no effect on those. We compared the transcriptome profiles of the ΔphoU2 and ΔphoU1 mutants with that of the parent strain. In the ΔphoU2 mutant, expression of genes related to inorganic phosphate uptake was significantly upregulated (pst operon) and the levels of intracellular inorganic polyphosphate (polyP) were increased. In the ΔphoU2 mutant, expression of enzymes in the pentose phosphate pathway (PPP) was downregulated and less NADP (NADPH) was detected, consistent with the high sensitivity to H2O2 and the growth retardation of the ΔphoU2 mutant. The upregulated expression of ATP synthase was consistent with the high intracellular ATP content in the ΔphoU2 mutant, which may have been related to the lower drug tolerance of the ΔphoU2 mutant. This study demonstrates that PhoU2, but not PhoU1, in S. epidermidis regulates bacterial growth, biofilm formation, oxidative stress, and drug tolerance in association with alterations to inorganic phosphate metabolism, the pentose phosphate pathway, galactose metabolism, the tricarboxylic acid (TCA) or citric cycle, glycolysis and gluconeogenesis, and respiratory reactions.IMPORTANCE PhoU is widely conserved throughout the bacterial kingdom and plays an important role in response to stress and metabolic maintenance. In our study, two PhoU homologs were found in S. epidermidis The function of phoU2, but not phoU1, in S. epidermidis is related to growth, drug tolerance, the oxidative stress response, polyP levels, and ATP accumulation. In addition, phoU2 regulates biofilm formation. Hence, phoU2 is a regulator of both drug tolerance and biofilm formation, which are two bacterial properties that present major challenges to the clinical treatment of infections. Analysis of differential gene expression revealed that phoU2 is involved in fundamental metabolic processes, such as the PPP pathway. These findings indicate that phoU2 is a crucial regulator in S. epidermidis.Entities:
Keywords: Staphylococcus epidermidis; biofilm; tolerance
Mesh:
Substances:
Year: 2017 PMID: 28947672 PMCID: PMC5686610 DOI: 10.1128/JB.00219-17
Source DB: PubMed Journal: J Bacteriol ISSN: 0021-9193 Impact factor: 3.490
FIG 1Two genes homologous to phoU, phoU1 and phoU2, were found in S. epidermidis RP62A by motif analysis according to the PhoU conserved motifs [E(D)XXXD] of Thermotoga maritima. (A) Genetic locations of phoU1 and phoU2 in S. epidermidis RP62A. (B) Genetic organization of the pst operon and phoU in E. coli.
FIG 2Effect of phoU2 deletion on the growth of S. epidermidis. Overnight cultures of the ΔphoU1, ΔphoU2, and SE1457 strains were diluted 1:200 into 10 ml TSB in a conical flask in a volume of 100 ml and incubated with shaking at 220 rpm. Bacterial growth was monitored by measuring the OD600 for 12 h. Data (means ± SDs) are from three independent experiments. (A) Growth curves of the ΔphoU1 and ΔphoU2 mutants under oxic conditions. (B) Growth curves of ΔphoU1 and ΔphoU2 mutants under microaerobic conditions. (C) Representative images showing the colony morphology of the ΔphoU1 and ΔphoU2 mutants and the SE1457 parent strain grown on TSB agar plates at 37°C for 24 h under oxic conditions. The results represent those from one of three independent experiments.
FIG 3(A) Bacterial morphology of the ΔphoU1 and ΔphoU2 mutants observed by TEM. The ultrastructure of the log-phase bacteria was observed by transmission electron microscopy (Philips Tecnai-12 Biotwin). Arrow, disruption of the cell wall in the ΔphoU2 mutant. (B) Autolysis of the ΔphoU1 and ΔphoU2 mutants induced by Triton X-100. Overnight cultures were suspended in Triton X-100 autolysis buffer (50 mM glycine, pH 8.0, containing 0.01% Triton X-100) to an initial OD600 of approximately 1.0, and the rates of autolysis were monitored on the basis of the decrease in the OD600 value over time.
FIG 4Biofilm (BF) formation by the ΔphoU1 and ΔphoU2 mutants on microtiter plates. Overnight cultures of the S. epidermidis strains were diluted 1:200 with fresh TSB, added to 96-well polystyrene plates in triplicate, and cultured under static conditions for 6 h, 12 h, 24 h, and 48 h. After the biofilms were washed, they were stained with crystal violet. The OD570s of the plates were analyzed. The experiments were repeated three times, and the data represent means ± SDs. **, P < 0.01.
FIG 5Biofilms of the ΔphoU1 and ΔphoU2 mutants observed by CLSM. Twenty-four-hour-old biofilms of SE1457 and the ΔphoU1 and ΔphoU2 mutants were grown on a cover glass in a cell culture dish and observed by CLSM. Three-dimensional (3-D) structural images (zoom 1, ×63 magnification) were reconstructed, and the thickness of the biofilms was measured using Imaris software. Viable and dead cells were stained green (SYTO9) and red (PI), respectively. The amount of fluorescence in the middle layer of the biofilm was determined using ImageJ software (zoom 3, ×63 magnification). The PI/total florescence value indicates the proportion of dead cells within the biofilm. The images and values are representative of those from one of three independent experiments.
FIG 6Biofilm formation by the ΔphoU1 and ΔphoU2 mutants under hydrodynamic conditions. Overnight cultures of the S. epidermidis strains were diluted 1:200 with fresh TSB and added to BioFlux 48-well plates. The bacteria were then cultured under hydrodynamic conditions with a shear setting of 0.15 dyne/cm2. A BioFlux 1000 system (Fluxion Biosciences) with a Leica microscope and temperature-controlled housing was used for all imaging experiments. Automated microscopy and image processing were performed with BioFlux Montage software. Images were automatically acquired every 10 min at multiple stage positions with bright-field illumination; images were also acquired in the red channel using a 200-ms exposure time. The background-corrected average pixel intensity per image was used to quantify the biofilm formation by the different strains. The curve was generated on the basis of the images. A synthesis of the images is shown in Movies S1 to S5 in the supplemental material. Each figure represents the results of one of three independent experiments.
FIG 7Initial attachment of the ΔphoU1 and ΔphoU2 mutants on polystyrene plates. Log-phase bacterial cultures in TSB were adjusted to an OD600 of 0.1 with PBS, and 5-ml aliquots were added to a 6-well polystyrene plate. After incubation at 37°C for 30 min, each well was washed three times with PBS, and the adhered cells were observed and photographed. The amounts of attached bacterial cells of the ΔphoU1 and ΔphoU2 mutants and SE1457 are indicated. The results (means ± SDs) are from three independent experiments. ***, P < 0.001.
FIG 8Effects of the ΔphoU1 and ΔphoU2 mutants on extracellular matrix biosynthesis by S. epidermidis. (A) Aap expression in the ΔphoU1 and ΔphoU2 mutants. Twenty-four-hour-old biofilms and 12-h-old planktonic bacteria were collected after they were washed with PBS. Lysostaphin-treated samples with identical OD600s were centrifuged at 20,000 × g for 30 min at 4°C. The supernatant was separated by 7% SDS-PAGE, and the gel pieces containing Aaps were used for Western blotting (top).The remaining gel pieces were stained with Coomassie blue as an endogenous reference (bottom). MAb18B6 (10 ng/ml) was used as the primary antibody. Immunoreactivity was detected using an ECL Western blotting system after incubation with HRP-conjugated secondary antibody. (B) PIA biosynthesis was semiquantified using a dot blot assay with WGA. Twenty-four-hour-old biofilms were scraped off and suspended in EDTA. Serial dilutions of the PIA assay extracts were spotted onto nitrocellulose membranes, subsequently incubated with WGA conjugated to HRP, and visualized by chromogenic detection. (C) eDNA quantified by qPCR of four chromosomal loci (gyrB, serp0306, leuA, and lysA). The OD600s of unwashed 24-h-old biofilms were measured for normalization to the biofilm biomass, and then the biofilms were used for eDNA isolation by phenol-chloroform-isoamyl alcohol extraction and ethanol precipitation. The results are presented as the amount of eDNA per biofilm biomass (means ± SDs) from three independent experiments.
Survival of the ΔphoU1 and ΔphoU2 mutants and the parent strain with antibiotic exposure over time
| Time point | No. of CFU/ml | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SE1457 | Δ | Δ | Δ | Δ | |||||||||||
| Van | Lev | Ami | Van | Lev | Ami | Van | Lev | Ami | Van | Lev | Ami | Van | Lev | Ami | |
| Start | 8 × 109 | 8 × 109 | 8 × 109 | 8.7 × 109 | 8.7 × 109 | 8.7 × 109 | 9 × 109 | 9 × 109 | 9 × 109 | 8.5 × 109 | 8.5 × 109 | 8.5 × 109 | 8.7 × 109 | 8.7 × 109 | 8.7 × 109 |
| 12 h | 6 × 106 | 4 × 106 | 7.2 × 106 | 8 × 106 | 7.8 × 106 | 4.4 × 106 | 8 × 105 | 5 × 104 | 6 × 105 | 6.8 × 106 | 5 × 106 | 7.8 × 106 | 7.6 × 106 | 5.7 × 104 | 4 × 105 |
| 24 h | 3.2 × 106 | 3.6 × 106 | 5 × 105 | 6 × 106 | 5 × 106 | 4 × 106 | 5 × 105 | 2 × 103 | 1 × 105 | 4 × 106 | 3.5 × 106 | 2 × 106 | 3.5 × 105 | 5 × 103 | 2.4 × 104 |
| 36 h | 9.2 × 105 | 7 × 105 | 4 × 105 | 1.2 × 106 | 2.4 × 106 | 2 × 106 | 5.4 × 105 | 0 | 6 × 104 | 2.2 × 106 | 8 × 105 | 7 × 105 | 4 × 104 | 0 | 2 × 103 |
| 48 h | 1.3 × 106 | 5 × 105 | 8.8 × 104 | 1.28 × 106 | 3 × 106 | 5 × 105 | 4 × 104 | 0 | 1.2 × 104 | 7 × 105 | 8 × 105 | 4.5 × 105 | 2.4 × 103 | 0 | 0 |
| 72 h | 4.4 × 106 | 2 × 105 | 6 × 104 | 2.57 × 106 | 5 × 105 | 4 × 105 | 0 | 0 | 0 | 5 × 105 | 4.6 × 105 | 9 × 104 | 0 | 0 | 0 |
| 96 h | 6 × 106 | 7 × 105 | 4 × 104 | 9 × 106 | 6.6 × 105 | 1 × 105 | 0 | 0 | 0 | 7.2 × 105 | 5 × 105 | 7.5 × 104 | 0 | 0 | 0 |
| 120 h | 1.9 × 105 | 6 × 105 | 1.9 × 104 | 6 × 106 | 4 × 105 | 8 × 104 | 0 | 0 | 0 | 2.4 × 105 | 4.5 × 105 | 5 × 104 | 0 | 0 | 0 |
The susceptibilities of stationary-phase cultures of the ΔphoU1 and ΔphoU2 mutants and the SE1457 parent strain to vancomycin (Van; 75 μg/ml), levofloxacin (Lev; 75 μg/ml), and amikacin (Ami; 50 μg/ml) were determined. The numbers of CFU were determined at different times of exposure of stationary-phase cultures of these strains to the indicated antibiotics.
Genes differentially expressed between the ΔphoU2 mutant and the parent strain
| Gene function and gene | GenBank accession no. (location) | Description of product | Fold change in expression by: | |
|---|---|---|---|---|
| RNA-Seq | RT-qPCR | |||
| Growth | ||||
| | DNA-binding response regulator YycF | 0.35 | 0.25 ± 0.08 | |
| | Sensor | 0.33 | 0.31 ± 0.14 | |
| | Pyruvate formate-lyase-activating enzyme | 0.14 | 0.12 ± 0.02 | |
| | Anaerobic ribonucleoside triphosphate reductase-activating protein | 0.31 | ND | |
| | Anaerobic ribonucleoside triphosphate reductase | 0.27 | 0.30 ± 0.14 | |
| Biofilm formation | ||||
| | Intercellular adhesion regulator | 4.58 | 4.20 ± 1.14 | |
| | Cell wall surface anchor family protein | 0.18 | 0.13 ± 0.04 | |
| | Sigma factor B regulatory protein | 0.31 | ND | |
| Autolysis | ||||
| | Secretory antigen precursor SsaA | 3.56 | ND | |
| | Secretory antigen precursor SsaA | 9.47 | ND | |
| | Secretory antigen precursor SsaA-related protein | 1.92 | ND | |
| | Secretory antigen precursor SsaA | 3.03 | ND | |
| | LysM domain-containing protein | 1.86 | ND | |
| Phosphate transport system | ||||
| | Phosphate transport system regulatory protein PhoU | 5.10 | 48.95 ± 6.43 | |
| | Phosphate transporter ATP-binding protein | 3.75 | 67.96 ± 12.14 | |
| | Phosphate ABC transporter permease | 2.29 | ND | |
| | Phosphate ABC transporter permease | 3.32 | ND | |
| | Phosphate ABC transporter phosphate-binding protein | 16.46 | ND | |
| | Phosphonate ABC transporter permease | 0.31 | ND | |
| | Phosphonate ABC transporter permease | 0.31 | ND | |
| | Phosphonate ABC transporter ATP-binding protein | 0.26 | ND | |
| | Phosphonate ABC transporter substrate-binding protein | 0.27 | ND | |
| | Phosphate transporter family protein | 0.20 | 0.35 ± 0.09 | |
| | Alpha-glucosidase | 0.38 | ND | |
| | Tagatose-1,6-diphosphate aldolase | 0.09 | ND | |
| | Galactose-6-phosphate isomerase subunit LacA | 0.06 | 0.13 ± 0.03 | |
| | 6-Phospho-beta-galactosidase | 0.24 | 0.33 ± 0.07 | |
| | UTP-glucose-1-phosphate uridylyltransferase | 0.47 | ND | |
| | PTS system, lactose-specific IIA component | 0.12 | ND | |
| | Phosphoglucomutase/phosphomannomutase | 0.51 | ND | |
| | Tagatose-6-phosphate kinase | 0.09 | ND | |
| Glycolysis/gluconeogenesis | ||||
| | Gluconokinase | 0.19 | 0.33 ± 0.12 | |
| | Glucose-6-phosphate isomerase | 0.51 | ND | |
| | 1-Phosphofructokinase | 21.66 | ND | |
| | Fructose-bisphosphate aldolase | 1.74 | ND | |
| | Glyceraldehyde-3-phosphate dehydrogenase | 0.62 | ND | |
| | Phosphoglycerate kinase | 0.35 | ND | |
| | Phosphoglyceromutase | 0.23 | ND | |
| | Pyruvate phosphate dikinase | 0.10 | 0.03 ± 0.01 | |
| | 1.54 | ND | ||
| | Alcohol dehydrogenase | 0.03 | 0.38 ± 0.09 | |
| | Fructose-1,6-bisphosphatase | 0.39 | ND | |
| Pentose phosphate pathway | ||||
| | Glucose-6-phosphate isomerase | 0.51 | ND | |
| | 0.63 | ND | ||
| | Glucose-1-dehydrogenase | 3.52 | ND | |
| | Deoxyribose-phosphate aldolase | 0.62 | ND | |
| | Ribose-phosphate pyrophosphokinase | 0.62 | ND | |
| | Transketolase | 0.59 | ND | |
| | Fructose-1,6-bisphosphatase | 0.39 | ND | |
| | Gluconokinase | 0.19 | ND | |
| | Phosphopentomutase | 0.62 | ND | |
| | Glucose-6-phosphate 1-dehydrogenase | 0.56 | ND | |
| | Phosphoglucomutase/phosphomannomutase | 0.51 | ND | |
| | Ribulose-phosphate 3-epimerase | 0.65 | ND | |
| | Aconitate hydratase | 0.64 | ND | |
| | Isocitrate dehydrogenase | 0.46 | ND | |
| | Branched-chain alpha-keto acid dehydrogenase subunit E2 | 0.24 | ND | |
| | Succinyl coenzyme A synthetase subunit beta | 1.78 | ND | |
| | Succinate dehydrogenase iron-sulfur subunit | 0.20 | ND | |
| | Succinate dehydrogenase flavoprotein subunit | 0.17 | ND | |
| | Fumarate hydratase | 0.51 | ND | |
| | 2-Oxoglutarate dehydrogenase E1 | 0.44 | ND | |
| | Dihydrolipoamide succinyltransferase | 0.25 | ND | |
| | Malate:quinone oxidoreductase | 0.43 | ND | |
| | Malate:quinone oxidoreductase | 0.48 | ND | |
| | Phosphoenolpyruvate carboxykinase | 0.53 | ND | |
| | 2-Oxoglutarate ferredoxin oxidoreductase subunit beta | 0.56 | ND | |
| | Pyruvate ferredoxin oxidoreductase, alpha subunit | 0.44 | ND | |
| | Acetoin dehydrogenase, E1 component, beta subunit | 0.33 | ND | |
| | Acetoin dehydrogenase, E3 component, dihydrolipoamide dehydrogenase | 1.55 | ND | |
| | 2-Oxoisovalerate dehydrogenase E2 | 0.51 | ND | |
| | 2-Oxoisovalerate dehydrogenase E1 | 0.40 | ND | |
| | 2-Oxoisovalerate dehydrogenase E1 | 0.32 | ND | |
| | 2-Oxoisovalerate dehydrogenase E3 | 0.34 | ND | |
| | NADH:flavin oxidoreductase/fumarate reductase, flavoprotein subunit | 0.02 | 0.082 | |
qRT-PCR data are given as the means ± standard deviations of the results from three independent experiment. ND, not done.
FIG 9Interaction networks between DEGs identified by transcriptome comparison. The proteins encoded by DEGs (red, green), which were identified by comparison (at 6 h) of the transcriptomes of the ΔphoU2 mutant and the parent strain, were extracted to construct a protein-protein interaction network. The lines in the network represent protein-protein interactions, including binding/association, phosphorylation, activation, and inhibition. Proteins encoded by upregulated and downregulated DEGs are indicated in red and green, respectively.
FIG 10Intracellular polyP, ATP, NADP, and NADPH in the ΔphoU2 mutant. Bacteria were grown to exponential phase in TSB medium. PolyP was assessed by measuring the fluorescence emission of the DAPI-polyP complex at 550 nm. (A) The fluorescence (in arbitrary units [AU]) of the DAPI-polyP complex was measured at 550 nm to evaluate the amount of intracellular polyP. (B) The amount of ATP was determined by measuring the fluorescence emission of the ATP complex at 587 nm. Bacteria were grown to exponential phase in TSB medium (OD600 = 0.5). (C and D) The amounts of total NADP and NADPH were measured using an NADP/NADPH quantification kit (Sigma). The amounts of total NADP and NADPH were determined by measuring the absorbance of the NADPH complex at 450 nm. Data (means ± SDs) are from three independent experiments. **, P < 0.01; *, P < 0.05.
FIG 11Sensitivity of the ΔphoU1 and ΔphoU2 mutants to H2O2 and SDS. Overnight cultures of the bacterial strains were diluted 1:200 in fresh TSB medium and incubated at 37°C with aeration for 3 h until the OD600 was approximately 2. After 2-fold serial dilution, each 5-μl aliquot was spotted onto a TSB agar plate containing 6 mM H2O2 or 0.006% SDS and incubated overnight at 37°C. The growth of colonies on plates containing H2O2 or SDS was photographed.
FIG 12Major metabolic pathways in the ΔphoU2 mutant revealed by DEGs. Shown are transcription of enzyme-encoding genes that were downregulated and upregulated, enzyme-encoding genes that were not found in DEGs (genes differentially expressed between the ΔphoU2 mutant and the parent strain), stimulatory reactions, prohibitory reactions, reversible reaction interactions between the two products, and products whose amounts were increased or decreased. The numbers represent the enzyme-encoding genes listed in Table 3. P, phosphate; CoA, coenzyme A.
DEGs involved in major metabolic pathway
| DEG no. | Gene name(s) | Enzyme(s) encoded |
|---|---|---|
| 1 | Galactose-6-phosphate isomerase subunit LacA, tagatose-1,6-diphosphate aldolase, 6-phospho-beta-galactosidase | |
| 2 | UTP-glucose-1-phosphate uridylyltransferase | |
| 3 | Phosphoglucomutase/phosphomannomutase | |
| 4 | Gluconokinase | |
| 5 | Glucose-6-phosphate isomerase | |
| 6 | 1-Phosphofructokinase | |
| 7 | Fructose-bisphosphate aldolase | |
| 8 | Glyceraldehyde-3-phosphate dehydrogenase, phosphoglycerate kinase, phosphoglyceromutase | |
| 9 | 2-Oxoglutarate ferredoxin oxidoreductase subunit beta, pyruvate ferredoxin oxidoreductase, alpha subunit | |
| 10 | Aconitate hydratase | |
| 11 | Aconitate hydratase | |
| 12 | Isocitrate dehydrogenase | |
| 13 | Branched-chain alpha-keto acid dehydrogenase subunit E2 | |
| 14 | Succinyl coenzyme A synthetase subunit beta | |
| 15 | Succinate dehydrogenase iron-sulfur subunit, succinate dehydrogenase flavoprotein subunit | |
| 16 | Fumarate hydratase | |
| 17 | Malate:quinone oxidoreductase, malate:quinone oxidoreductase | |
| 18 | 2-Oxoisovalerate dehydrogenase E2, 2-oxoisovalerate dehydrogenase E1, 2-oxoisovalerate dehydrogenase E1, 2-oxoisovalerate dehydrogenase E3 | |
| 19 | Glucose-6-phosphate 1-dehydrogenase | |
| 20 | Ribulose-phosphate 3-epimerase | |
| 21 | Phosphopentomutase | |
| 22 | Deoxyribose-phosphate aldolase | |
| 23 | Ribose-phosphate pyrophosphokinase | |
| 24 | ||
| 25 | Transketolase |
Bacterial strains and plasmids used in the present study
| Bacterial strain or plasmid | Description | Source |
|---|---|---|
| Bacterial strains | ||
| | Clinical strain, biofilm positive | |
| Δ | This study | |
| Δ | This study | |
| Δ | This study | |
| Δ | This study | |
| | Standard strain, biofilm positive | ATCC |
| | Standard strain, biofilm negative | ATCC |
| | Restriction-deficient strain permitting shuttle of a plasmid modified by its host specificity determination from Gram-negative to Gram-positive bacteria | Gao Fu, University of Hong Kong |
| Plasmids | ||
| pKOR1 | Temp-sensitive | Li Min, Institute of Antibiotics, Huashan Hospital |
| pKOR1-Δ | Recombinant plasmid | This study |
| pKOR1-Δ | Recombinant plasmid | This study |
| pCN51 | A Cd2+-inducible shuttle plasmid, Ermr | Wageningen University, Holland |
| pCN51- | A Cd2+-inducible shuttle plasmid, Ermr; the | This study |
Primers used in this study
| Primer use and primer | Primer sequence (5′–3′) | Location | Size of PCR product (bp) | Note |
|---|---|---|---|---|
| Construction of Δ | ||||
| | 974705–974724 | 1,061 | ||
| | GG | 973625–973645 | KpnI | |
| | GG | 972969–972991 | 823 | KpnI |
| | 972127–972147 | |||
| Construction of Δ | ||||
| | 319402–319419 | 1,100 | ||
| | GG | 320480–320501 | KpnI | |
| | GG | 321114–321135 | 959 | KpnI |
| | 322053–322072 | |||
| Construction of Δ | ||||
| | CGC | BamHI | ||
| | CGG | KpnI | ||
| RT-qPCR | ||||
| | AGAAGAGGAAGTTAGAGAAGA | 2611073–2611093 | 168 | |
| | GCATATCC ACTGTTATATTGAAG | 2610926–2610948 | ||
| | CGTCTTGGTCTTCGTGTA | 973556–973573 | 169 | |
| | CAATAGGTTGTTGTCTCGTAAT | 973405–973426 | ||
| | GCTGTAGGATTACTTGTAGAC | 320874–320894 | 200 | |
| | GCTTGACACTTATCTGCTATT | 321073–321053 |
Primers were designed according to the genomic sequence of S. epidermidis RP62A (GenBank accession number NC_002976). F, forward primer; R, reverse primer.
Location of the primer in the genomic sequence of S. epidermidis RP62A.
The underlined sequences represent the BP reaction sites or restriction enzyme sites.